Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-02-14 3:54 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC C SLRX | ARMISTICE CAPITAL LLC | 427,350 9.99% | 427,350 (New Position) | View |
| 2023-10-27 3:57 pm Purchase | 13D | SALARIUS PHARMACEUTICALS INC C SLRX | Lee Elvin Sanghwan | 204,270 6.09% | 204,270 (New Position) | View |
| 2023-02-13 4:30 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC C SLRX | Lind Global Fund II LP | 89,092 3.8% | 89,092 (New Position) | View |
| 2022-04-29 4:31 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Lind Global Fund II LP | 2,969,718 5.3% | 2,969,718 (New Position) | View |
| 2022-04-27 10:52 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Lincoln Park Capital Fund LLC | 2,969,718 5.98% | 2,969,718 (New Position) | View |
| 2022-02-10 4:05 pm Sale | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Sio Capital Management LLC | 1,354,291 3% | -302,951 (-18.28%) | View |
| 2021-02-16 1:03 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Sio Capital Management LLC | 1,657,242 8.35% | 1,657,242 (New Position) | View |
| 2021-02-16 10:07 am Unchanged | 13G | SALARIUS PHARMACEUTICALS INC SLRX | CVI Investments Inc. | 804,347 4.1% | 0 (Unchanged) | View |
| 2021-02-11 7:15 pm Sale | 13G | SALARIUS PHARMACEUTICALS INC SLRX | HIRSCHMAN ORIN | 1,166,619 4.99% | -50,771 (-4.17%) | View |
| 2021-01-28 2:25 pm Sale | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Empery Asset Management LP | 804,347 3.9% | -445,653 (-35.65%) | View |
| 2020-08-04 09:18 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | Empery Asset Management LP | 1,250,000 6.9% | 1,250,000 (New Position) | View |
| 2020-02-20 5:39 pm Sale | 13D | SALARIUS PHARMACEUTICALS INC SLRX | Sharma Sunil | 234,571 1.82% | -112,777 (-32.47%) | View |
| 2020-02-20 5:35 pm Purchase | 13D | SALARIUS PHARMACEUTICALS INC SLRX | Northrup Jonathan P | 364,413 2.83% | 20,400 (+5.93%) | View |
| 2020-02-18 08:00 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | INTRACOASTAL CAPITAL LLC | 661,104 4.99% | 661,104 (New Position) | View |
| 2020-02-14 2:48 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | ARMISTICE CAPITAL LLC | 634,763 4.99% | 634,763 (New Position) | View |
| 2020-02-14 08:58 am Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | CVI Investments Inc. | 804,347 6.9% | 804,347 (New Position) | View |
| 2020-02-13 3:16 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | HIRSCHMAN ORIN | 1,217,390 9.47% | 1,217,390 (New Position) | View |
| 2020-02-12 6:58 pm Purchase | 13G | SALARIUS PHARMACEUTICALS INC SLRX | RENAISSANCE TECHNOLOGIES LLC | 58,819 1.45% | 58,819 (New Position) | View |
| 2019-07-29 5:27 pm Purchase | 13D | SALARIUS PHARMACEUTICALS INC SLRX | Sharma Sunil | 347,348 9.27% | 347,348 (New Position) | View |
| 2019-07-29 5:27 pm Purchase | 13D | SALARIUS PHARMACEUTICALS INC SLRX | Northrup Jonathan P | 344,013 9.18% | 344,013 (New Position) | View |